Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: Qurs-i-Kafur 10.5 grams will be given in thre divided doses(each tablet will contain 875mg) for 90 days.: It is a classical unani formulation taken from Al Qabadeen. The formulation co
Sponsors
Central Council for Research in Unani Medicine (CCRUM),110058 New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age group between 18-70 years 2) Patients irrespective of gender 3) Fasting plasma glucose levels between 126-150 mg/dl OR 4) 2-hour post-prandial plasma glucose level between 200-250 mg/dl OR 5) HbA1c level between 6.5-8%
Exclusion criteria
Exclusion criteria: 1) Pregnant and lactating mothers. 2) Subject with the fasting glucose level more than 150 mg/dl 3)Post-prandial glucose level more than 250 mg/dl 4) HbA1c more than 8 5) Subjects on insulin therapy 6) Known cases of Type-2 Diabetes mellitus with complications of ketoacidosis, Diabetic Nephropathy, Diabetic retinopathy 7) Known cases of Type-1 Diabetes mellitus / Gestational Diabetes mellitus 8) Known cases of significant pulmonary, cardio-vascular, hepato- renal dysfunction 9) Uncontrolled hypertension 10) Known cases of polycythemia, iron deficiency aneamia, hemoglobinopathies 11) Patient not willing to attend treatment schedule regularly 12)Patients on double or triple combination therapy for Type-2 Diabetes mellitus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)HbA1C 2)Fasting blood glucose levels 3)2-Hour PPBG levels 4)Fasting urine for glucose and ketones estimation 5)Mean blood glucose levelsTimepoint: 1)HbA1C (At baseline And 91ist day of the Study) 2)Fasting blood glucose levels(at baseline,15th,30th,45th,60th,75th and 91ist day of the study ) 3)2-Hour PPBG levels(At baseline,15th day,30th day,45th day,60th day,75th day and 91ist day of the study) 4)Fasting urine for glucose and ketones estimation (At baseline and 91ist day of the study) 5)Mean blood glucose levels(At Baseline and 91ist day of the study) | — |
Secondary
| Measure | Time frame |
|---|---|
| A)Arbitary scale for the evaluavation of the subjective parameters which include 1)Polydypsia 2)Polyuria 3)Polyphagia 4)Loss of weight 5)Loss of libido 6)Giddiness 7)Nocturia 8)Fatigue 9)Burning sensation in palms and soles 10)VAS for the Pain B)Lipid ProfiLe,CBC with ESR,LFT,KFT,Na+,K+ and ECG C)Assessement of Quality of life with MDQoL-17Timepoint: A)Subjective parameters are to be evaluated at baseline,15th,30th,45th,60th,75th and 91ist day B) Lipid Profile,CBC with ESR,LFT,KFT,Sodium, potassium and ECG at the baseline and 91ist day of the study. C)Assessement of Quality of life with MDQoL-17 at baseline and 91ist day. | — |
Countries
India
Contacts
Public ContactShugufta Hamid
Department of Moalajat Regional Research Institueof Unani Medicine ,Naseem bagh,University of Kashmir
Outcome results
None listed